Sid Devarakonda
Distinguished in Lung Adenocarcinoma
Distinguished in Lung Adenocarcinoma

Overview

Dr. Devarakonda trained and worked on faculty at the Washington University in St. Louis before joining Swedish. His research is focused on understanding cancers utilizing sequencing technologies. He has an excellent understanding of the latest advances in thoracic oncology (lung cancer, thymic malignancies, mesothelioma). He believes in providing the same level of care for his patients that he expects for his own family. His list of peer-reviewed scientific publications can be accessed here https://pubmed.ncbi.nlm.nih.gov/?term=Devarakonda+S&cauthor_id=34591593.

Dr. Devarakonda is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.

His clinical research consists of co-authoring 50 peer reviewed articles and participating in 18 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 10 articles in the study of Lung Adenocarcinoma.

Graduate Institution
Indira Gandhi Medical College , 2009, 2009
Residency
St. Luke's Cornwall Hospital , 2014
Specialties
Oncology
Licenses
Internal Medicine in MO
Board Certifications
American Board Of Internal Medicine
Fellowships
Barnes,Jewish Hospital/Washington University , 2017
Hospital Affiliations
Swedish Edmonds Hospital
Swedish Medical Center / Cherry Hill
Swedish Issaquah
Swedish Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Group Health Cooperative
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Lifewise

Accepted plan types not found. Please verify directly with the provider.

Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Prominence Health
  • EPO
  • PPO
Regence
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Medical Oncology - Swedish Cancer Institute First Hill
1221 Madison Street, 0, Seattle, WA 98104

Additional Areas of Focus

Dr. Devarakonda has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Lung Cancer
Mesothelioma
Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


18 Clinical Trials

A Phase II Study of Maintenance Vorolanib and Atezolizumab in Patients With Extensive-stage SCLC
Phase II Study of a Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer
Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC (RamAtezo-1)
View 15 Less Clinical Trials
Similar Doctors
Distinguished in Lung Adenocarcinoma
Oncology | Hematology Oncology
Distinguished in Lung Adenocarcinoma
Oncology | Hematology Oncology

The Association Of University Physicians

825 Eastlake Ave E, 
Seattle, WA 
 (1.2 miles away)
Languages Spoken:
English, Castilian, Hindi, Korean, Punjabi, Spanish
Accepting New Patients
Offers Telehealth

Christina Baik is an Oncologist and a Hematologist Oncology provider in Seattle, Washington. Dr. Baik is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Baik is currently accepting new patients.

Distinguished in Lung Adenocarcinoma
Distinguished in Lung Adenocarcinoma

The Association Of University Physicians

1959 Ne Pacific St, 
Seattle, WA 
 (2.8 miles away)
Languages Spoken:
English, Filipino, French, Hindi, Korean, Spanish
Accepting New Patients
Offers Telehealth

Keith Eaton is an Oncologist in Seattle, Washington. Dr. Eaton is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Salivary Gland Tumors, and Small Cell Lung Cancer (SCLC). Dr. Eaton is currently accepting new patients.

Joseph Rosales
Distinguished in Lung Adenocarcinoma
Oncology | Hematology
Distinguished in Lung Adenocarcinoma
Oncology | Hematology

Franciscan Oncology At St. Joseph

1617 South J Street, 
Tacoma, WA 
 (26.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

"Joseph Rosales, MD, has been a physician for over 20 years and a hematologist-oncologist in Western Washington since 2011 -- in Seattle, Federal Way and Tacoma. He is experienced in general hematology and oncology, with specialties in breast and thoracic oncology. Dr. Rosales considers himself a guide in his patients’ therapeutic journey. He meets his patients wherever they are - physically and emotionally - and strives to provide them the knowledge and perspective required to navigate difficult decisions in their care. His treatment philosophy has been consistent: to make sure that the patient remains in as much control of their care as possible while getting the best care possible.Dr. Rosales also maintains activity within the community, including involvement in oncologic education and advocacy. He received the2022 Binaytara Foundation for Excellence in Cancer Care ""Rising Star in Health Equity"" awardfor his demonstration of excellent leadership in improving cancer care in underprivileged communities.Multidisciplinary Lung Cancer Treatment during Covid-19 Video". Dr. Rosales is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Devarakonda's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
    View All 17 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile